Diagnosing growth hormone deficiency requires multiple tests. Some children with short stature may show subnormal growth hormone responses but still not benefit from growth hormone therapy.
Area of Science:
Pediatric Endocrinology
Growth Hormone Physiology
Diagnostic Testing
Background:
Short stature in children can have various causes, including growth hormone (GH) deficiency.
Standard provocative tests like insulin tolerance test (ITT) and arginine infusion test (AIT) are used to assess GH secretion.
Interpreting subnormal GH responses requires careful consideration of individual growth patterns and potential confounding factors.
Purpose of the Study:
To evaluate the necessity of multiple provocative tests for diagnosing growth hormone deficiency in children with short stature.
To determine if children with subnormal GH responses to ITT and AIT would benefit from GH therapy.
To investigate the impact of sex steroid pretreatment on GH provocative testing.
Main Methods:
Five prepubertal males (10-14 years) with short stature, normal growth rates, and bone ages underwent multiple GH stimulation tests.
Initial tests included insulin-induced hypoglycemia and arginine infusion.
Subsequent tests involved glucagon stimulation, tolbutamide-induced hypoglycemia, and repeat ITT/AIT after sex steroid pretreatment.
Main Results:
All five subjects exhibited subnormal peak GH responses (≤5 ng/ml) to initial ITT and AIT.
Four out of five subjects demonstrated at least one normal GH response to subsequent provocative tests.
Two subjects previously treated with GH for six months showed no characteristic growth response of GH deficiency.
Conclusions:
Subnormal GH response to single provocative tests does not definitively confirm GH deficiency or predict response to GH therapy.
Multiple provocative GH testing is crucial for accurate diagnosis and to identify children unlikely to benefit from GH therapy.
Sex steroid pretreatment may enhance GH release in some children, aiding in test interpretation.